Glaukos Corp - Asset Resilience Ratio
Glaukos Corp (GKOS) has an Asset Resilience Ratio of 19.30% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See GKOS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Glaukos Corp's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see GKOS total assets.
Liquid Assets Composition Over Time
This chart breaks down Glaukos Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Glaukos Corp total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $172.44 Million | 19.3% |
| Total Liquid Assets | $172.44 Million | 19.30% |
Asset Resilience Insights
- Good Liquidity Position: Glaukos Corp maintains a healthy 19.30% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Glaukos Corp Industry Peers by Asset Resilience Ratio
Compare Glaukos Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161 |
Medical Devices | 6.28% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Ningbo David Medical Device Co Ltd
SHE:300314 |
Medical Devices | 5.11% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.27% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
Annual Asset Resilience Ratio for Glaukos Corp (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Glaukos Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 21.04% | $187.95 Million | $893.49 Million | +5.72pp |
| 2024-12-31 | 15.32% | $149.29 Million | $974.76 Million | -6.16pp |
| 2023-12-31 | 21.48% | $201.96 Million | $940.41 Million | -0.23pp |
| 2022-12-31 | 21.71% | $233.17 Million | $1.07 Billion | -6.05pp |
| 2021-12-31 | 27.76% | $313.34 Million | $1.13 Billion | -2.85pp |
| 2020-12-31 | 30.61% | $307.77 Million | $1.01 Billion | +16.98pp |
| 2019-12-31 | 13.63% | $111.55 Million | $818.40 Million | -39.84pp |
| 2018-12-31 | 53.47% | $110.67 Million | $206.97 Million | -3.52pp |
| 2017-12-31 | 56.99% | $94.51 Million | $165.84 Million | -9.45pp |
| 2016-12-31 | 66.43% | $89.27 Million | $134.37 Million | +6.82pp |
| 2015-12-31 | 59.62% | $69.55 Million | $116.66 Million | +59.39pp |
| 2014-12-31 | 0.23% | $60.00K | $26.02 Million | +0.04pp |
| 2013-12-31 | 0.19% | $60.00K | $30.88 Million | -- |
About Glaukos Corp
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for a… Read more